US Stock MarketDetailed Quotes

PRME Prime Medicine

Watchlist

4.420
+0.280+6.76%

Close Aug 23 16:00 ET

4.410
-0.010-0.23%

Post 20:01 ET

530.54MMarket Cap-2036P/E (TTM)

Prime Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

591K

Operating revenue

--0

--591K

--0

Cost of revenue

Gross profit

Operating expense

23.01%55.67M

22.23%48.93M

64.14%191.29M

40.99%54.54M

62.56%51.46M

72.05%45.26M

101.19%40.03M

37.96%116.54M

-35.60%38.69M

203.59%31.66M

Selling and administrative expenses

18.23%12.6M

21.91%11.16M

45.50%43.39M

35.94%13.08M

58.78%10.49M

44.71%10.66M

47.13%9.15M

114.16%29.82M

33.92%9.63M

118.30%6.61M

-General and administrative expense

18.23%12.6M

21.91%11.16M

45.50%43.39M

35.94%13.08M

58.78%10.49M

44.71%10.66M

47.13%9.15M

114.16%29.82M

33.92%9.63M

118.30%6.61M

Research and development costs

24.49%43.07M

22.33%37.77M

70.54%147.91M

42.66%41.46M

63.56%40.97M

82.68%34.6M

125.78%30.88M

22.93%86.73M

-45.05%29.06M

238.47%25.05M

Operating profit

-23.01%-55.67M

-20.75%-48.34M

-64.14%-191.29M

-40.99%-54.54M

-62.56%-51.46M

-72.05%-45.26M

-101.19%-40.03M

-37.96%-116.54M

35.60%-38.69M

-203.59%-31.66M

Net non-operating interest income expense

-3.78%611K

635K

Non-operating interest income

-3.78%611K

----

--635K

----

Other net income (expense)

-117.64%-400K

525.35%2.71M

-14.38%-7.12M

-1,317.62%-11.1M

-74.45%643K

165.08%2.27M

109.70%434K

92.35%-6.23M

46.15%-783K

130.13%2.52M

Gain on sale of security

-831.94%-1.93M

168.55%1.17M

70.69%-2.38M

137.16%635K

-188.26%-1.58M

107.06%263K

62.07%-1.7M

-1,978.77%-8.13M

-16.58%-1.71M

121.41%1.79M

Special income (charges)

----

---13.5M

----

--0

----

-Less:Other special charges

----

--13.5M

----

Other non- operating income (expenses)

-4.88%39K

-27.49%1.55M

360.43%8.76M

90.60%1.77M

205.22%2.22M

-82.77%41K

19,309.09%2.14M

102.35%1.9M

7,616.67%926K

72,900.00%728K

Income before tax

-30.95%-55.46M

-15.22%-45.63M

-61.61%-198.41M

-66.32%-65.64M

-74.40%-50.82M

-42.18%-42.35M

-62.48%-39.6M

25.98%-122.77M

35.85%-39.47M

-55.14%-29.14M

Income tax

-532.26%-134K

166.34%134K

70.57%-279K

-150.94%-108K

107.01%31K

62.03%-202K

-95.06%-948K

-113.47%-186K

108.95%212K

Net income

-30.53%-55.33M

-16.15%-45.76M

-62.64%-198.13M

-67.10%-65.64M

-72.77%-50.71M

-44.42%-42.39M

-65.26%-39.4M

26.33%-121.82M

37.56%-39.28M

-78.83%-29.35M

Net income continuous Operations

-30.53%-55.33M

-16.15%-45.76M

-62.64%-198.13M

-67.10%-65.64M

-72.77%-50.71M

-44.42%-42.39M

-65.26%-39.4M

26.33%-121.82M

37.56%-39.28M

-78.83%-29.35M

Minority interest income

Net income attributable to the parent company

-30.53%-55.33M

-16.15%-45.76M

-62.64%-198.13M

-67.10%-65.64M

-72.77%-50.71M

-44.42%-42.39M

-65.26%-39.4M

26.33%-121.82M

37.56%-39.28M

-78.83%-29.35M

Preferred stock dividends

16.83%20.19M

-79.35%1.31M

-0.02%6.36M

Other preferred stock dividends

Net income attributable to common stockholders

-30.53%-55.33M

-16.15%-45.76M

-39.52%-198.13M

-61.69%-65.64M

-41.99%-50.71M

-18.92%-42.39M

-31.04%-39.4M

22.87%-142.01M

41.40%-40.6M

-56.80%-35.71M

Basic earnings per share

2.13%-0.46

0.00%-0.44

47.97%-2.18

-28.57%-0.72

-45.29%-0.55

5.32%-0.47

-5.08%-0.44

-63.39%-4.19

41.96%-0.56

-19.34%-0.3786

Diluted earnings per share

2.13%-0.46

0.00%-0.44

47.97%-2.18

-28.57%-0.72

-45.29%-0.55

5.32%-0.47

-5.08%-0.44

-63.39%-4.19

41.96%-0.56

-19.34%-0.3786

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	0	591K	0	0	0	0	0	0	0	0
Operating revenue	--0	--591K	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	23.01%55.67M	22.23%48.93M	64.14%191.29M	40.99%54.54M	62.56%51.46M	72.05%45.26M	101.19%40.03M	37.96%116.54M	-35.60%38.69M	203.59%31.66M
Selling and administrative expenses	18.23%12.6M	21.91%11.16M	45.50%43.39M	35.94%13.08M	58.78%10.49M	44.71%10.66M	47.13%9.15M	114.16%29.82M	33.92%9.63M	118.30%6.61M
-General and administrative expense	18.23%12.6M	21.91%11.16M	45.50%43.39M	35.94%13.08M	58.78%10.49M	44.71%10.66M	47.13%9.15M	114.16%29.82M	33.92%9.63M	118.30%6.61M
Research and development costs	24.49%43.07M	22.33%37.77M	70.54%147.91M	42.66%41.46M	63.56%40.97M	82.68%34.6M	125.78%30.88M	22.93%86.73M	-45.05%29.06M	238.47%25.05M
Operating profit	-23.01%-55.67M	-20.75%-48.34M	-64.14%-191.29M	-40.99%-54.54M	-62.56%-51.46M	-72.05%-45.26M	-101.19%-40.03M	-37.96%-116.54M	35.60%-38.69M	-203.59%-31.66M
Net non-operating interest income expense	-3.78%611K					635K
Non-operating interest income	-3.78%611K	----	----	----	----	--635K	----	----	----	----
Other net income (expense)	-117.64%-400K	525.35%2.71M	-14.38%-7.12M	-1,317.62%-11.1M	-74.45%643K	165.08%2.27M	109.70%434K	92.35%-6.23M	46.15%-783K	130.13%2.52M
Gain on sale of security	-831.94%-1.93M	168.55%1.17M	70.69%-2.38M	137.16%635K	-188.26%-1.58M	107.06%263K	62.07%-1.7M	-1,978.77%-8.13M	-16.58%-1.71M	121.41%1.79M
Special income (charges)	----	----	---13.5M	----	----	----	----	--0	----	----
-Less:Other special charges	----	----	--13.5M	----	----	----	----	----	----	----
Other non- operating income (expenses)	-4.88%39K	-27.49%1.55M	360.43%8.76M	90.60%1.77M	205.22%2.22M	-82.77%41K	19,309.09%2.14M	102.35%1.9M	7,616.67%926K	72,900.00%728K
Income before tax	-30.95%-55.46M	-15.22%-45.63M	-61.61%-198.41M	-66.32%-65.64M	-74.40%-50.82M	-42.18%-42.35M	-62.48%-39.6M	25.98%-122.77M	35.85%-39.47M	-55.14%-29.14M
Income tax	-532.26%-134K	166.34%134K	70.57%-279K	0	-150.94%-108K	107.01%31K	62.03%-202K	-95.06%-948K	-113.47%-186K	108.95%212K
Net income	-30.53%-55.33M	-16.15%-45.76M	-62.64%-198.13M	-67.10%-65.64M	-72.77%-50.71M	-44.42%-42.39M	-65.26%-39.4M	26.33%-121.82M	37.56%-39.28M	-78.83%-29.35M
Net income continuous Operations	-30.53%-55.33M	-16.15%-45.76M	-62.64%-198.13M	-67.10%-65.64M	-72.77%-50.71M	-44.42%-42.39M	-65.26%-39.4M	26.33%-121.82M	37.56%-39.28M	-78.83%-29.35M
Minority interest income
Net income attributable to the parent company	-30.53%-55.33M	-16.15%-45.76M	-62.64%-198.13M	-67.10%-65.64M	-72.77%-50.71M	-44.42%-42.39M	-65.26%-39.4M	26.33%-121.82M	37.56%-39.28M	-78.83%-29.35M
Preferred stock dividends								16.83%20.19M	-79.35%1.31M	-0.02%6.36M
Other preferred stock dividends
Net income attributable to common stockholders	-30.53%-55.33M	-16.15%-45.76M	-39.52%-198.13M	-61.69%-65.64M	-41.99%-50.71M	-18.92%-42.39M	-31.04%-39.4M	22.87%-142.01M	41.40%-40.6M	-56.80%-35.71M
Basic earnings per share	2.13%-0.46	0.00%-0.44	47.97%-2.18	-28.57%-0.72	-45.29%-0.55	5.32%-0.47	-5.08%-0.44	-63.39%-4.19	41.96%-0.56	-19.34%-0.3786
Diluted earnings per share	2.13%-0.46	0.00%-0.44	47.97%-2.18	-28.57%-0.72	-45.29%-0.55	5.32%-0.47	-5.08%-0.44	-63.39%-4.19	41.96%-0.56	-19.34%-0.3786
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall